Magazine Article | September 1, 2023

To America, A New Biopharma Model

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

Most Americans welcome new arrivals to their country. New arrivals create. New arrivals build. New arrivals bring fresh talent, skills, ideas, and more from their heritage and personal accomplishments. Case in point: Ketan Mehta, founder and CEO of Tris Pharma. Mehta came to the United States from his birthplace in Mumbai, India, when he was a young man in the late 1970s. Since then, he has built a career in pharma and, more recently, an entirely new company with a triad of businesses — platform technology licensing, generic medicines, and new drug development.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader